PharmaResearch Co., Ltd. (KOSDAQ:214450)
315,500
-17,500 (-5.26%)
At close: Mar 9, 2026
PharmaResearch Market Cap
PharmaResearch has a market cap or net worth of 3.28 trillion as of March 9, 2026. Its market cap has increased by 18.61% in one year.
Market Cap
3.28T
Enterprise Value
2.98T
Revenue
496.03B
Ranking
n/a
PE Ratio
21.72
Stock Price
315,500.00
Market Cap Chart
Since July 24, 2015, PharmaResearch's market cap has increased from 1.01T to 3.28T, an increase of 224.79%. That is a compound annual growth rate of 11.73%.
Market Cap History
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| SK bioscience | 3,431.52B |
| D&D Pharmatech | 3,652.62B |
| OliX Pharmaceuticals | 4,179.31B |
| Hugel | 2,824.54B |
| Orum Therapeutics | 2,490.56B |
| Voronoi | 5,927.74B |
| Peptron | 6,132.46B |
| Chabiotech | 1,820.72B |